Hemostatic agent, Factor VIII replacement therapy Medicines in UAE | Complete List & Information

About Hemostatic agent, Factor VIII replacement therapy Medicines

This page lists all Hemostatic agent, Factor VIII replacement therapy medicines available in UAE pharmacies. Click on any medicine name to view detailed information including uses, dosage, side effects, and availability.

Complete List of Hemostatic agent, Factor VIII replacement therapy Medicines

Antihemophilic Factor (Recombinant) Fc Fusion Protein

Brand: ELOCTATE | Strength: 1000 IU | Form: Powder For Solution For Intravenous Injection

Class: | Hemostatic agent, Factor VIII replacement therapy Use: | Treatment and prevention of bleeding episodes in patients with hemophilia A (congenital factor VIII deficiency) Adult dose: | 50 I...

Antihemophilic Factor (Recombinant) Fc Fusion Protein

Brand: ELOCTATE | Strength: 500 IU | Form: Powder For Solution For Intravenous Injection

Class: | Hemostatic agent, Factor VIII replacement therapy Use: | Treatment and prevention of bleeding episodes in patients with hemophilia A Adult dose: | 50 IU/kg to 100 IU/kg administered intra...

Antihemophilic Factor (Recombinant) Fc Fusion Protein (Efmoroctocog alfa)

Brand: ELOCTA | Strength: 1000 IU | Form: Powder For Solution For Intravenous Injection

Class: | Hemostatic agent, Factor VIII replacement therapy Use: | Treatment and prevention of bleeding episodes in patients with hemophilia A (congenital factor VIII deficiency) Adult dose: | 50 I...

Antihemophilic Factor (Recombinant) Fc Fusion Protein (Efmoroctocog alfa)

Brand: ELOCTA | Strength: 1500 IU | Form: Powder For Solution For Intravenous Injection

Class: | Hemostatic agent, Factor VIII replacement therapy Use: | Treatment and prophylaxis of bleeding episodes in patients with hemophilia A (congenital factor VIII deficiency) Adult dose: | 50 ...

Antihemophilic Factor (Recombinant) Fc Fusion Protein (Efmoroctocog alfa)

Brand: ELOCTA | Strength: 2000 IU | Form: Powder For Solution For Intravenous Injection

Class: | Hemostatic agent, Factor VIII replacement therapy Use: | Treatment and prevention of bleeding episodes in patients with hemophilia A (congenital factor VIII deficiency) Adult dose: | 50 I...

Antihemophilic Factor (Recombinant) Fc Fusion Protein (Efmoroctocog alfa)

Brand: ELOCTA | Strength: 3000 IU | Form: Powder For Solution For Intravenous Injection

Class: | Hemostatic agent, Factor VIII replacement therapy Use: | Treatment and prophylaxis of bleeding episodes in patients with hemophilia A (congenital factor VIII deficiency) Adult dose: | 50 ...